A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1997
11/27/1997	WO1997044058A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997	WO1997044054A2 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997	WO1997044038A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
11/27/1997	WO1997044031A1 Agent for treating allergic dermatitis
11/27/1997	CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997	CA2256568A1 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	CA2256109A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997	CA2255650A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
11/27/1997	CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	CA2252537A1 Benzofuran carboxamides and their therapeutic use
11/26/1997	EP0808897A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/26/1997	EP0808846A2 Peptides which react with antiboby representing the prognostic marker for HIV disease progression
11/26/1997	EP0808843A2 Novel macrolide compound 0406
11/26/1997	EP0808365A1 Human interleukin-1 receptor accessory protein
11/26/1997	EP0808330A1 A process for preparing certain aza cyclohexapeptides
11/26/1997	EP0700398B1 Psoralen derivatives, their preparation and use as medicaments
11/26/1997	EP0580829B1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract
11/26/1997	CN1165655A Method of treating conditions with estrogen agonists
11/26/1997	CN1165651A Use of (E)-1£4'-(2-alkylaminoethioxy) phenyl\|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
11/26/1997	CN1036520C 1,4-diazepine derivative prepn. method
11/25/1997	US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes
11/25/1997	US5691382 Enzyme inhibitors for cardiovascular disorders
11/25/1997	US5691381 Antagonist of tumor necrosis factor, antiinflammatory agent, antiarthritic agent
11/25/1997	US5691373 Nonpeptide endothelin antagonists I
11/25/1997	US5691334 Immunomodulators for skin grafts, autoimmune and for organ transplants
11/25/1997	US5691167 DNA encoding allergenic proteins and peptides from Johnson grass pollen
11/25/1997	US5690933 Administering a non-depleting anti-cd4 monoclonal antibody to treat a disorder mediated by an immune reaction to a self-antigen
11/22/1997	CA2205077A1 Peptides which react with antibody representing the prognostic marker for hiv disease progression
11/20/1997	WO1997043251A1 Compounds with anti-inflammatory and immunosuppressive activities
11/20/1997	WO1997043250A1 Hydroxamic acid based inhibitors of the formation of cd23 and tnf
11/20/1997	WO1997043249A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
11/20/1997	WO1997042979A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	WO1997042973A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
11/20/1997	WO1997042947A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	DE19632823C1 Complexes of (+)-S-adenosyl-methionine and 3'-azido-2',3'-di:deoxy nucleoside compounds
11/20/1997	DE19613976C1 Thalidomid-Prodrugs mit immunmodulatorischer Wirkung Thalidomide prodrugs with immunomodulatory effect
11/20/1997	CA2254126A1 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	CA2253602A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
11/20/1997	CA2253590A1 Inhibitors of the production of s-cd23 and the secretion of tnf
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807175A2 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
11/19/1997	EP0807166A1 A method of preparing an undifferentiated cell
11/19/1997	EP0807124A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0807105A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
11/19/1997	CN1165035A Antigen-antibody-recombination DNA composite type vaccin
11/18/1997	US5688992 Compounds for treatment of signaling pathways in immune disfunction, cancer and diabetes
11/18/1997	US5688922 Chemical intermediates for glycyrrhetinic acid derivatives, selectin ligands, inhibitors of leukotriene biosynthesis
11/18/1997	US5688825 Sulfonyloxysuccimides
11/18/1997	US5688805 Inhibitors of tumor necrosis factor-a, treatment of septic shock, antiinflammatory, antiallergen
11/18/1997	US5688772 Quinoa saponin compositions and methods of use
11/18/1997	US5688688 Vector for expression of a polypeptide in a mammalian cell
11/18/1997	US5688532 Aqueous solution of zinc chloride or zinc sulfate, treatment of hay fever and asthma
11/18/1997	US5688529 Immunosuppresants, antiinflammatory, antitumor, antiproliferative, antiviral, antipsoriatic agents
11/18/1997	CA2122360C Quinazolinone antianginal agents
11/13/1997	WO1997042324A1 Use of interleukin-10 to produce a population of suppressor cells
11/13/1997	WO1997042319A1 NOVEL Fas ANTIGEN DERIVATIVES
11/13/1997	WO1997042214A1 Androstene derivatives
11/13/1997	WO1997042187A1 Oxindole derivatives
11/13/1997	WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997	WO1997041897A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041884A1 Method of treatment
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041862A1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents
11/13/1997	WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997	CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
11/13/1997	CA2253930A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253803A1 Use of interleukin-10 to produce a population of suppressor cells
11/13/1997	CA2253494A1 Novel fas antigen derivative
11/12/1997	EP0806423A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
11/12/1997	EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
11/12/1997	EP0805796A1 Cell adhesion inhibitors
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/12/1997	EP0805686A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases
11/12/1997	EP0805683A1 5-carboxamido or 5-fluoro]- 2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/12/1997	EP0805628A1 Receptor specific transepithelial transport of immunogens
11/12/1997	EP0600026B1 Cardiac output probe assembly
11/12/1997	CN1164872A Novel compounds
11/12/1997	CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them
11/12/1997	CN1036393C 7-(2-aminoethyl)-benzothiazolones
11/11/1997	US5686615 Stereoselective preparation of substituted piperidines
11/11/1997	US5686609 Aromatic amine compounds, Their method of preparation and pharmaceutical compositions in which they are present
11/11/1997	US5686496 Aromatic ether amidine used for treating diseases involve inflammatory and/or allergic processes
11/11/1997	US5686457 Pyrrolopyrimidine derivatives having pharmacological activity
11/11/1997	US5686455 Imidazole derivatives and their use as cytokine inhibitors
11/11/1997	US5686435 Vitamin D amide derivatives
11/11/1997	US5686434 3-aryl-2-isoxazolines as antiinflammatory agents
11/11/1997	US5686431 Methods of using low molecular weight heparins for treatment of pathological processes
11/11/1997	US5686426 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
11/11/1997	US5686414 Methods of treating conditions associated with corneal transplantation
11/11/1997	US5686068 Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof
11/11/1997	US5685195 Crank assembly for a screen wiper drive of an automotive vehicle
11/06/1997	WO1997041440A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	WO1997041244A1 Vaccines for treatment of lymphoma and leukemia

1 ... 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 ... 1172